Lv7
3370 积分 2022-04-14 加入
HER2-targeted therapies: Unraveling their role in biliary tract cancers
1个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
1个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
1个月前
已完结
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
3个月前
已完结
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
3个月前
已完结
Potential Synergies for Combined Targeted Therapy in the Treatment of Neuroendocrine Cancer
3个月前
已完结
FXR–YAP signalling maintains biliary epithelial cell identity and preserves liver homeostasis
3个月前
已完结
Early-activated extracellular matrix proteins shape the metabolic and spatial dynamics of the kidney fibrotic microenvironment
4个月前
已完结
Metabolic regulation by tanycyte-derived extracellular vesicles through insulin precursor-mediated neuronal recognition and mTORC component delivery
4个月前
已完结
Lipid-dependent accrual of a subset of monocyte-derived macrophages is essential for tissue regeneration
4个月前
已完结
皖公网安备34019202002308
